KNWN - Know Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Know Labs, Inc.

500 Union Street
Suite 810
Seattle, WA 98101
United States

IndustryScientific & Technical Instruments
Full Time Employees7

Key Executives

NameTitlePayExercisedYear Born
Mr. Ronald P. EricksonFounder, Chairman, Interim CFO & Treasurer180kN/A1944
Mr. Phillip A. BosuaCEO & Director273.6kN/A1974
Mr. Michael GrabhamChief Bus. OfficerN/AN/A1963
Dr. James H. Anderson Jr., M.D.Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardN/AN/AN/A
Mr. Jeffrey Richard KrusePres of TransTech Systems IncN/AN/A1958
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Know Labs, Inc., develops, markets, and sells proprietary technology solution for authenticating or diagnosing substances or materials. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy along the electromagnetic spectrum to perform analytics, which allow the user to identify, authenticate, and diagnose materials and substances. The company, through its subsidiary TransTech Systems, Inc., distributes products for employee and personnel identification and authentication. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is based in Seattle, Washington.

Corporate Governance

Know Labs, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.